Drug Profile
DSP 1053
Alternative Names: DSP1053Latest Information Update: 20 Jul 2023
Price :
$50
*
At a glance
- Originator Dainippon Sumitomo Pharma
- Developer Sumitomo Pharma America
- Class Antidepressants
- Mechanism of Action Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Depressive disorders